| Main Subject |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Team Building > Self-Esteem and Beethoven |
|
Main Subject - Self-Esteem and Beethoven
Good leaders are always building and maintaining the self-esteem of their team
members. In fact, this skill may very we According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product ll be the cornerstone of effective leadership.
However, leaders often move too quickly to take the care needed to do th ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in is
effectively when providing feedback. The result can be both the loss of loyalty and
talent. Both come with a high lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. price tag to the organization. To illustrate the fragile nature of self-esteem, consider for a moment one of the world here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe s finest musicians: Beethoven. The film, “Immortal Beloved,” is about the life of
Beethoven and while it has a fictiona d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro l story line, it also offers many true scenes from
this great masters life. In one such scene, Beethoven is conducting ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc his own composition (imagine that for a
moment) but he is completely deaf. This fact, however, has not yet been discov easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi red
by his audience or the community at large. Shortly into the piece, the orchestra
becomes completely frustrated wi nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically th Beethoven and literally stops playing. The
audience is quite entertained and begins laughing due to their perception and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ of his lack
of competence. Beethoven is devistated by their response and leaves the concert
hall immediately. It is ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi a painful example of the fragility of self-esteem, and how
easy it is for us to jump to conclusions about someone’s be ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a havior and be totally off
the mark. When confronted with performance that falls short of an expectation:
dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod e time to gather facts and observe the employee before having a
conversation.
cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin n first and try to understand the situation
from their perspective before providing your own observations.
tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen t if the expectations are clearly understood, or if there are other factors
you may not know behind this performance.
t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust they are off track. They need and want you to
hold them accountable. Make a contract together for the expected improvem y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products ents
and follow up to see that these promises are kept. By not jumping to conclusions you give your team member t . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de he benefit of the
doubt. You are saying, look I do not know all there is to know about you and your
job, tell me; I elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip trust you. You'll gain perspective that builds both the relationship and
the performance of your employee and your team tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:How To Conduct Effective Online Surveys Supply And Demand And Marketing
|